A 64-year-old man presents with acute anterior wall myocardial infarction (troponin I 4.2 ng/mL). He undergoes coronary stent placement and is started on aspirin. Vital signs: BP 118/76, HR 92, RR 16, Temp 37°C, SpO2 98%. He is prescribed a second antiplatelet agent that irreversibly inhibits the P2Y12 receptor and blocks ADP-induced platelet aggregation. He denies any prior bleeding disorders. Which medication was most likely added to his dual antiplatelet therapy regimen?
- A)Heparin
- B)ClopidogrelGABARITO
- C)Alteplase
- D)Eptifibatide
- E)Abciximab
Explicação
Clopidogrel irreversibly inhibits the platelet ADP receptor P2Y12, thereby reducing expression of GPIIb/IIIa and inhibiting platelet aggregation. Dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor is standard after coronary stent placement. The mech... Ver explicação completa e trilha adaptativa →